Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer by Jun Li, Yafei Bo, Bo Ding, Lei Wang

“…Reduction of SHMT2 level to one-fourth was observed in the advancedgastric cancer stages of USP32 silenced tissue.Conclusion: USP32 had a direct role in regulating SHMT2 expression, which attracted therapeutic target for futuretreatment.…”
Get full text

Rectal cancer survival and prognostic factors in Iranian population: A retrospective cohort study by Seyed Kazem Mirinezhad, Mostafa Akbarzadeh-Khiavi, Farshad Seyednejad, Mohammad Hossein Somi

“…Statistical analysis revealed several significant prognostic factors, including age, education, symptoms, and cancer stage. In the multivariate Cox proportional-hazards analysis, advanced regional stage (HR = 1.54, 95 % CI, 1.13–2.08), presence of metastasis (HR = 3.73, 95 % CI, 2.49–5.58), and age over 70 (HR = 1.65) were associated with a higher risk of mortality. …”
Get full text

Surgical intervention may be a therapeutic option for NSCLC patients with AJCC stage IV: a large population-based study by Wang H, Yan L, Li C, Wang Z

“…In our study, we mainly focused on the surgical therapeutic option for NSCLC patients with American Joint Committee on Cancer stage IV.Patients and methods: Using the Surveillance Epidemiology and End Results database, we screened out an appropriate patient population with stage IV NSCLC treated between 2004 and 2013. …”
Get full text

Capabilities of intraoperative photodynamic therapy for treatment of locally advanced breast cancer by E. V. Filonenko, E. K. Saribekyan, V. I. Ivanova-Radkevich

“…The developed method was approved in 79 patients with locally advanced breast cancer stage IIB and IIIA,B,C with poor prognostic factors. …”
Get full text

Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells by Yong Soo Jang, Tae Wan Kim, Jae Sung Ryu, Hye Jeong Kong, Si Hyeong Jang, Gye Hyun Nam, Jae Hoon Kim, Seob Jeon

“…However, IHC results revealed no correlation between PD-L1 expression and patient survival or cancer stage. CD68 expression was significantly increased in cancer cells compared to normal or benign ovarian tumor cells, but it was not associated with the survival outcomes of ovarian cancer patients. …”
Get full text

The impact of COVID‐19 on presentation and diagnosis of head and neck squamous cell carcinoma by Jason R. Crossley, Lacey L. Nelson, Hunter VanDolah, Bruce J. Davidson, Jessica H. Maxwell

“…There was a greater than 50% decrease in new tumor board case presentations per month in the COVID cohort (4.8) relative to the pre‐COVID (10.9) cohort. Cancer stage at presentation was similar between cohorts. …”
Get full text

Anxiety, Depression, and Colorectal Cancer Survival: Results from Two Prospective Cohorts by Claudia Trudel-Fitzgerald, Shelley S. Tworoger, Xuehong Zhang, Edward L. Giovannucci, Jeffrey A. Meyerhardt, Laura D. Kubzansky

“…Comparable results were observed across all sensitivity analyses (introducing a 1-year lag, restricting to CRC-related mortality, considering potential behavioral pathways) and stratified models (cancer stage, sex). Our findings suggest greater anxiety and depression symptoms can not only impede adherence to healthy habits and reduce quality of life in cancer patients but could also be a marker for accelerated CRC progression.…”
Get full text

DcR3 in All Its Aspects by Nazlı Helvacı, Hifa Gülru Çağlar, Alev Kural

“…According to several research, the level of DcR3 in the blood is linked to cancer stage in cancer patients. High DcR3 levels in serum or tissues have been found to be associated with poor prognosis and/or resistance to therapy in some cancer patients. …”
Get full text

Identification of cytokine-induced cell communications by pan-cancer meta-analysis by Yining Liu, Min Zhao, Hong Qu

“…Interestingly, the tumor samples with mutations in any of the 84 cytokines and receptors have a substantially higher mutational burden, offering insights into antitumor immune regulation and response. Clinical cancer stage information revealed that tumor samples with mutations in any of the 84 cytokines and receptors stratify into earlier tumor stages, with unique cellular compositions and clinical outcomes. …”
Get full text

Impact of COVID-19 on the clinical staging of breast cancer: A cross-sectional study by Thais Zilles Fritsch, Gabriel Ben Bordinhão, Laura Martin Manfroi, Rafaela Vidal Paiva de Sousa, Maiara Rosa dos Santos, Giovana Diniz de Oliveira Bonetti, Rafael José Vargas Alves, Claudia Giuliano Bica

Get full text

Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer by Alisa D. Kjaergaard, Inna M. Chen, Astrid Z. Johansen, Børge G. Nordestgaard, Stig E. Bojesen, Julia S. Johansen

“…CRP performed best in patients with advanced and CA 19-9 in patients with low cancer stages. YKL-40 was not associated with mortality and, therefore, was not included in the biomarker score. …”
Get full text

Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis by Yan Li, Xueyan Liang, Huijuan Li, Tong Yang, Sitong Guo, Xiaoyu Chen

“…The subgroup analysis illustrated that the probability of cost-effectiveness was >50% in the Barcelona Clinic Liver Cancer Stage B subgroups for nivolumab at a WTP threshold of $150,000/QALY. …”
Get full text

Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study by Pipit Burasakarn, Sermsak Hongjinda, Anuparp Thienhiran, Nichaphat Phancharoenkit, Pusit Fuengfoo

“…Background: Transarterial chemoembolization (TACE) is reserved for the treatment of intermediate hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer stage B); however, it can also be utilized as a neoadjuvant treatment prior to surgical resection in resectable HCC cases. …”
Get full text

Dose Delays, Dose Reductions, and Relative Total Dose Intensity in Patients With Advanced Cancer Who Exercised During Neoadjuvant Chemotherapy Treatment by Karen Y. Wonders PhD, FACSM, Kathryn Schmitz PhD, MPH, FACSM, Jay Harness MD

“…Data collection included baseline patient demographics and clinical characteristics, including age at diagnosis, cancer stage at initial diagnosis, chemotherapy regimen, and planned dose and schedule. …”
Get full text

The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer by Jing Na, Ya Li, Jun Wang, Xinyou Wang, JunLing Lu, Shichao Han

“…There was no significant relationship between multiple HPV infections and cervical cancer stage, lesion size, pathological tissue type, tissue differentiation degree/vascular cancer thrombus, and lymph node metastasis, and there was no significant difference in the results between the groups. …”
Get full text

Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study. by Shunsuke Mori, Yukitaka Ueki, Mizue Hasegawa, Kazuyoshi Nakamura, Kouya Nakashima, Toshihiko Hidaka, Koji Ishii, Hironori Kobayashi, Tomoya Miyamura

“…In addition to clinical cancer stage and no surgery within 1 month, RA and CPFE were identified as independent predictive factors for increased lung cancer-related mortality (RA: adjusted hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.65-4.76; CPFE: adjusted HR 2.01; 95% CI 1.24-3.23).…”
Get full text

Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database by Xiaoduo Li, Qiao Yang, Mingjing Chen, Changqing Yang, Jianfen Gu, Qiang Dong, Guangrong Yang

“…Univariate and multivariate analyses indicated that older age, higher tumor grade and advanced American Joint Committee on Cancer stage were adverse prognostic factors in both groups, while surgery and chemotherapy were protective factors. …”
Get full text

Crossing the River by Feeling the Stones: Experiences with PD-1 Inhibitors in Geriatric Oncology People, a Case Report and Literature Review by Yin H, Zhang X, Zhang M, Tang H, Zhang C, Li J

“…This case analysis focuses on an elderly patient with non-small cell lung cancer stage IV. The patient was an 86-year-old female with poor nutritional status and low body weight (27 kg) and could not tolerate platinum-based dual-drug first-line chemotherapy. …”
Get full text

ANALISIS BIAYA TERAPI PADA PASIEN KANKER PAYUDARA RAWAT INAP YANG MENJALANI KEMOTERAPI DI RSUP DR. SARDJITO YOGYAKARTA TAHUN 2012 by , SEPTIAN FAJAR, , Dr. Tri Murti Andayani, Sp.FRS., Apt.

“…Factors that affect the amount of total cost are the age of the patients (p = 0,003), breast cancer stage (p = 0,000), chemotherapy regimen (p = 0,000), the presence of another disease (p = 0,000), length of stay in hospital (p = 0,000), room class of hospitalized patients (p = 0,000), and the payment line of the patients (p = 0,000).…”

BIAYA PENGOBATAN PASIEN KANKER PAYUDARA STADIUM AWAL YANG MENDAPATKAN KEMOTERAPI KOMBINASI 5- FLUOROURASIL, DOKSORUBISIN, SIKLOFOSFAMID (FAC) DENGAN KEMOTERAPI KOMBINASI BERBASIS T... by , Didik Setiawan S. Farm, , Prof. dr. Iwan Dwiprahasto, M.Med.Sc., Ph.D.

“…It seen at longer length of stay, lower in completed chemotherapy cycle and worse survival profile for each breast cancer stage and age. Patient with taxan combination has a higher compliance in chemotherapy schedule. …”